Continued effectiveness of relapse prevention cognitive-behavioral therapy following fluoxetine treatment in youth with major depressive disorder / Graham J. Emslie en Journal of the American Academy of Child & Adolescent Psychiatry, Año 2015 - Vol.54 - No.12 (Diciembre)

Público ISBD [artículo]  inJournal of the American Academy of Child & Adolescent Psychiatry > Año 2015 - Vol.54 - No.12 (Diciembre) . - pp. 991–998 Título : Continued effectiveness of relapse prevention cognitive-behavioral therapy following fluoxetine treatment in youth with major depressive disorder Tipo de documento: texto impreso Autores: Graham J. Emslie, Autor ; Betsy D. Kennard, Autor ; Taryn L. Mayes, Autor Fecha de publicación: 2020 Artículo en la página: pp. 991–998 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Depresión, Recaída, Juventud, TCC, Tratamiento de continuación Resumen: To evaluate the continued effect of a sequential treatment strategy (fluoxetine followed by continued medication plus relapse prevention cognitive-behavioral therapy [RP-CBT]) on relapse prevention beyond the treatment phase. Link: ./index.php?lvl=notice_display&id=22587 [artículo] Continued effectiveness of relapse prevention cognitive-behavioral therapy following fluoxetine treatment in youth with major depressive disorder [texto impreso] / Graham J. Emslie, Autor ; Betsy D. Kennard, Autor ; Taryn L. Mayes, Autor . - 2020 . - pp. 991–998. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of the American Academy of Child & Adolescent Psychiatry > Año 2015 - Vol.54 - No.12 (Diciembre) . - pp. 991–998 Palabras clave: Depresión, Recaída, Juventud, TCC, Tratamiento de continuación Resumen: To evaluate the continued effect of a sequential treatment strategy (fluoxetine followed by continued medication plus relapse prevention cognitive-behavioral therapy [RP-CBT]) on relapse prevention beyond the treatment phase. Link: ./index.php?lvl=notice_display&id=22587

Long term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment / Benedetto Vitiello en The Journal of Clinical Psychiatry, Año 2011 - Vol.72 - No. 3 (Marzo)

Público ISBD [artículo]  inThe Journal of Clinical Psychiatry > Año 2011 - Vol.72 - No. 3 (Marzo) . - pp. 388-396 Título : Long term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment : a follow up study of the TORDIA sample Tipo de documento: texto impreso Autores: Benedetto Vitiello, Autor ; Graham J. Emslie, Autor ; Gregory Clarke, Autor Fecha de publicación: 2022 Artículo en la página: pp. 388-396 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos, Terapia de conducta cognitiva, Terapia de modalidad combinada, Trastorno depresivo mayor, Ideación suicida. Resumen: We examined the long-term outcome of participants in the Treatment of SSRI-Resistant Depression in Adolescents (TORDIA) study, a randomized trial of 334 adolescents (aged 12-18 years) with DSM-IV-defined major depressive disorder initially resistant to selective serotonin reuptake inhibitor (SSRI) treatment who were subsequently treated for 12 weeks with another SSRI, venlafaxine,... Link: ./index.php?lvl=notice_display&id=27963 [artículo] Long term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment : a follow up study of the TORDIA sample [texto impreso] / Benedetto Vitiello, Autor ; Graham J. Emslie, Autor ; Gregory Clarke, Autor . - 2022 . - pp. 388-396. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The Journal of Clinical Psychiatry > Año 2011 - Vol.72 - No. 3 (Marzo) . - pp. 388-396 Palabras clave: Antidepresivos, Terapia de conducta cognitiva, Terapia de modalidad combinada, Trastorno depresivo mayor, Ideación suicida. Resumen: We examined the long-term outcome of participants in the Treatment of SSRI-Resistant Depression in Adolescents (TORDIA) study, a randomized trial of 334 adolescents (aged 12-18 years) with DSM-IV-defined major depressive disorder initially resistant to selective serotonin reuptake inhibitor (SSRI) treatment who were subsequently treated for 12 weeks with another SSRI, venlafaxine,... Link: ./index.php?lvl=notice_display&id=27963

Predictors of response to treatment in children and adolescents with mood disorders / Graham J. Emslie en Psychiatric Clinics of North America, Año 2003 - Vol. 26 No. 2 (Junio)

Público ISBD [artículo]  inPsychiatric Clinics of North America > Año 2003 - Vol. 26 No. 2 (Junio) . - pp. 435-456 Título : Predictors of response to treatment in children and adolescents with mood disorders Tipo de documento: texto impreso Autores: Graham J. Emslie, Autor ; Taryn L. Mayes, Autor ; Rebecca S. Laptook, Autor Fecha de publicación: 2020 Artículo en la página: pp. 435-456 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos, Biomarcadores, Comorbilidad, Demografía, Familia, Trastornos del estado de ánimo. Resumen: Depression and bipolar disorder are frequently chronic disorders, with onset often beginning in childhood. Mood disorders are becoming more recognized in children and adolescents, and treatment of these disorders has received much attention, particularly in the past 10 years. Link: ./index.php?lvl=notice_display&id=24815 [artículo] Predictors of response to treatment in children and adolescents with mood disorders [texto impreso] / Graham J. Emslie, Autor ; Taryn L. Mayes, Autor ; Rebecca S. Laptook, Autor . - 2020 . - pp. 435-456. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Psychiatric Clinics of North America > Año 2003 - Vol. 26 No. 2 (Junio) . - pp. 435-456 Palabras clave: Antidepresivos, Biomarcadores, Comorbilidad, Demografía, Familia, Trastornos del estado de ánimo. Resumen: Depression and bipolar disorder are frequently chronic disorders, with onset often beginning in childhood. Mood disorders are becoming more recognized in children and adolescents, and treatment of these disorders has received much attention, particularly in the past 10 years. Link: ./index.php?lvl=notice_display&id=24815

Updates in the pharmacologic treatment of childhood depression / Graham J. Emslie en Psychiatric Clinics of North America, Año 2000- Vol. 23 No. 4 (Diciembre)

Público ISBD [artículo]  inPsychiatric Clinics of North America > Año 2000- Vol. 23 No. 4 (Diciembre) . - pp. 813-835 Título : Updates in the pharmacologic treatment of childhood depression Tipo de documento: texto impreso Autores: Graham J. Emslie, Autor ; Taryn L. Mayes, Autor ; Carroll W. Hughes, Autor Fecha de publicación: 2020 Artículo en la página: pp. 813-835 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno depresivo, Morbilidad, Mortalidad, Pediatría, Trastorno depresivo mayor infantil, Trastorno del estado de ánimo, Depresión. Resumen: Depressive disorders are a leading cause of morbidity and mortality in the pediatric age group,14, 42, 98 with a prevalence rate of up to 8.3%.19, 42, 58, 59, 77, 78, 79, 123 This prevalence is comparable to that for adults66 and is greater in adolescents than in children. Link: ./index.php?lvl=notice_display&id=24911 [artículo] Updates in the pharmacologic treatment of childhood depression [texto impreso] / Graham J. Emslie, Autor ; Taryn L. Mayes, Autor ; Carroll W. Hughes, Autor . - 2020 . - pp. 813-835. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Psychiatric Clinics of North America > Año 2000- Vol. 23 No. 4 (Diciembre) . - pp. 813-835 Palabras clave: Trastorno depresivo, Morbilidad, Mortalidad, Pediatría, Trastorno depresivo mayor infantil, Trastorno del estado de ánimo, Depresión. Resumen: Depressive disorders are a leading cause of morbidity and mortality in the pediatric age group,14, 42, 98 with a prevalence rate of up to 8.3%.19, 42, 58, 59, 77, 78, 79, 123 This prevalence is comparable to that for adults66 and is greater in adolescents than in children. Link: ./index.php?lvl=notice_display&id=24911

---

1 (1 - 4 / 4)